Amanote Research

Amanote Research

    RegisterSign In

PET With the 89Zr-Labeled Transforming Growth Factor- Antibody Fresolimumab in Tumor Models

Journal of Nuclear Medicine - China
doi 10.2967/jnumed.111.092809
Full Text
Open PDF
Abstract

Available in full text

Categories
MedicineNuclear MedicineRadiologyImaging
Date

November 9, 2011

Authors
T. H. Oude MunninkM. E. A. ArjaansH. Timmer-BosschaC. P. SchroderJ. W. HesselinkS. R. VedelaarA. M. E. WalenkampM. ReissR. C. GregoryM. N. Lub-de HoogeE. G. E. de Vries
Publisher

Society of Nuclear Medicine


Related search

Immuno-Pet Imaging of 89Zr Labeled Anti-Pd-L1 Domain Antibody

English

PET of C-Met in Cancer With 64Cu-Labeled Hepatocyte Growth Factor

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2015English

Feasibility of Real-Time in Vivo 89Zr-Dfo-Labeled CAR T-Cell Trafficking Using PET Imaging

PLoS ONE
Multidisciplinary
2020English

Transforming Growth Factor

2020English

Tumor Necrosis Factor - Α and Transforming Growth Factor - Β1 Polymorphisms in Bronchial Asthma

Indian Journal of Medical Sciences
Medicine
2008English

Transforming Growth Factor Beta Regulation of Tumor Progression in Metastatic Cancer

2004English

Transforming Growth Factor Β

2017English

Transforming Growth Factor-Β

2005English

Development of 68Ga- And 89Zr-Labeled Exendin-4 as Potential Radiotracers for the Imaging of Insulinomas by PET

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy